Form 4 UNITED THERAPEUTICS Corp For: Aug 15 Filed by: ROTHBLATT MARTINE A
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
United Therapeutics Corp. (UTHR) PT Raised to $380 at Wells Fargo
August 20, 2024 4:53 AM EDTWells Fargo analyst Tiago Fauth raised the price target on United Therapeutics Corp. (NASDAQ: UTHR) to $380.00 (from $350.00) while maintaining a Overweight rating.
The analyst comments "Thoughts on the stock. We previously modeled Yutrepia launching this year, as the FDA faced no legal hurdles in... More
